Agenus shared on LinkedIn:
“The Agenus team is live at AACR 25, where Dr. Anthony El-khoueiry is sharing the latest data from botensilimab/balstilimab in treatment-refractory hepatocellular carcinoma (HCC).
Read more about AACR 25 on OncoDaily.
Agenus shared on LinkedIn:
“The Agenus team is live at AACR 25, where Dr. Anthony El-khoueiry is sharing the latest data from botensilimab/balstilimab in treatment-refractory hepatocellular carcinoma (HCC).
Read more about AACR 25 on OncoDaily.